Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, therapy sequence, ALL, Leukemia, multiple myeloma, bone marrow, Lymphoma (any), Diseases, Therapies, Combinations, Hodgkin Lymphoma, CAR-Ts, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Plasma Cell Disorders, immunotherapy, Cell Lineage, Lymphoid Malignancies, Study Population, Clinically relevant, transplantation, vaccines
Type: Oral
Hematology Disease Topics & Pathways:
Biological, therapy sequence, ALL, Leukemia, multiple myeloma, bone marrow, Lymphoma (any), Diseases, Therapies, Combinations, Hodgkin Lymphoma, CAR-Ts, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Plasma Cell Disorders, immunotherapy, Cell Lineage, Lymphoid Malignancies, Study Population, Clinically relevant, transplantation, vaccines
Monday, December 7, 2020: 9:00 AM-10:30 AM
Moderators:
Sairah Ahmed, MD, MD Anderson Cancer Center
and
Mehdi Hamadani, MD, Medical College of Wisconsin
Disclosures:
Ahmed: Tessa Therapeutics: Membership on an entity's Board of Directors or advisory committees. Hamadani: ADC Therapeutics: Membership on an entity's Board of Directors or advisory committees; Takeda Pharmaceutical Company; Spectrum Pharmaceuticals; Astellas Pharma: Research Funding; Sanofi Genzyme, AstraZeneca: Speakers Bureau; Janssen R&D; Incyte Corporation; ADC Therapeutics; Celgene Corporation; Pharmacyclics, Omeros, AbGenomics, Verastem, TeneoBio: Consultancy.
9:00 AM
9:15 AM
9:30 AM
9:45 AM
10:00 AM
10:15 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH